Global Radioactive Therapeutic Drugs Supply, Demand and Key Producers, 2023-2029
The global Radioactive Therapeutic Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Nuclear medicine therapy uses radiopharmaceuticals targeting specific tumors, such as thyroid tumors, lymphomas, or bone metastases, to deliver radiation to neoplastic lesions as part of a therapeutic strategy to cure, alleviate, or control the disease.
This report studies the global Radioactive Therapeutic Drugs demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Radioactive Therapeutic Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Radioactive Therapeutic Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Radioactive Therapeutic Drugs total market, 2018-2029, (USD Million)
Global Radioactive Therapeutic Drugs total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Radioactive Therapeutic Drugs total market, key domestic companies and share, (USD Million)
Global Radioactive Therapeutic Drugs revenue by player and market share 2018-2023, (USD Million)
Global Radioactive Therapeutic Drugs total market by Type, CAGR, 2018-2029, (USD Million)
Global Radioactive Therapeutic Drugs total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Radioactive Therapeutic Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Nihon Medi-Physics, ITM Isotopen Technologien Mьnchen AG, Advanced Accelerator Applications, Telix Pharmaceuticals, GE Healthcare, Theragnostics Ltd., NuView Life Sciences, Jubilant Pharma Limited and Lantheus Holdings, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Radioactive Therapeutic Drugs market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Radioactive Therapeutic Drugs Market, By Region:
1. How big is the global Radioactive Therapeutic Drugs market?
2. What is the demand of the global Radioactive Therapeutic Drugs market?
3. What is the year over year growth of the global Radioactive Therapeutic Drugs market?
4. What is the total value of the global Radioactive Therapeutic Drugs market?
5. Who are the major players in the global Radioactive Therapeutic Drugs market?
Nuclear medicine therapy uses radiopharmaceuticals targeting specific tumors, such as thyroid tumors, lymphomas, or bone metastases, to deliver radiation to neoplastic lesions as part of a therapeutic strategy to cure, alleviate, or control the disease.
This report studies the global Radioactive Therapeutic Drugs demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Radioactive Therapeutic Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Radioactive Therapeutic Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Radioactive Therapeutic Drugs total market, 2018-2029, (USD Million)
Global Radioactive Therapeutic Drugs total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Radioactive Therapeutic Drugs total market, key domestic companies and share, (USD Million)
Global Radioactive Therapeutic Drugs revenue by player and market share 2018-2023, (USD Million)
Global Radioactive Therapeutic Drugs total market by Type, CAGR, 2018-2029, (USD Million)
Global Radioactive Therapeutic Drugs total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Radioactive Therapeutic Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Nihon Medi-Physics, ITM Isotopen Technologien Mьnchen AG, Advanced Accelerator Applications, Telix Pharmaceuticals, GE Healthcare, Theragnostics Ltd., NuView Life Sciences, Jubilant Pharma Limited and Lantheus Holdings, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Radioactive Therapeutic Drugs market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Radioactive Therapeutic Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Oncology
- Cardiology
- Others
- Hospitals
- Academic & Research Institutes
- Others
- Nihon Medi-Physics
- ITM Isotopen Technologien Mьnchen AG
- Advanced Accelerator Applications
- Telix Pharmaceuticals
- GE Healthcare
- Theragnostics Ltd.
- NuView Life Sciences
- Jubilant Pharma Limited
- Lantheus Holdings, Inc.
- Curium Pharma
- Bayer AG
- Clarity Pharmaceuticals
1. How big is the global Radioactive Therapeutic Drugs market?
2. What is the demand of the global Radioactive Therapeutic Drugs market?
3. What is the year over year growth of the global Radioactive Therapeutic Drugs market?
4. What is the total value of the global Radioactive Therapeutic Drugs market?
5. Who are the major players in the global Radioactive Therapeutic Drugs market?
1 SUPPLY SUMMARY
1.1 Radioactive Therapeutic Drugs Introduction
1.2 World Radioactive Therapeutic Drugs Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Radioactive Therapeutic Drugs Total Market by Region (by Headquarter Location)
1.3.1 World Radioactive Therapeutic Drugs Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Radioactive Therapeutic Drugs Market Size (2018-2029)
1.3.3 China Radioactive Therapeutic Drugs Market Size (2018-2029)
1.3.4 Europe Radioactive Therapeutic Drugs Market Size (2018-2029)
1.3.5 Japan Radioactive Therapeutic Drugs Market Size (2018-2029)
1.3.6 South Korea Radioactive Therapeutic Drugs Market Size (2018-2029)
1.3.7 ASEAN Radioactive Therapeutic Drugs Market Size (2018-2029)
1.3.8 India Radioactive Therapeutic Drugs Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Radioactive Therapeutic Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Radioactive Therapeutic Drugs Major Market Trends
2 DEMAND SUMMARY
2.1 World Radioactive Therapeutic Drugs Consumption Value (2018-2029)
2.2 World Radioactive Therapeutic Drugs Consumption Value by Region
2.2.1 World Radioactive Therapeutic Drugs Consumption Value by Region (2018-2023)
2.2.2 World Radioactive Therapeutic Drugs Consumption Value Forecast by Region (2024-2029)
2.3 United States Radioactive Therapeutic Drugs Consumption Value (2018-2029)
2.4 China Radioactive Therapeutic Drugs Consumption Value (2018-2029)
2.5 Europe Radioactive Therapeutic Drugs Consumption Value (2018-2029)
2.6 Japan Radioactive Therapeutic Drugs Consumption Value (2018-2029)
2.7 South Korea Radioactive Therapeutic Drugs Consumption Value (2018-2029)
2.8 ASEAN Radioactive Therapeutic Drugs Consumption Value (2018-2029)
2.9 India Radioactive Therapeutic Drugs Consumption Value (2018-2029)
3 WORLD RADIOACTIVE THERAPEUTIC DRUGS COMPANIES COMPETITIVE ANALYSIS
3.1 World Radioactive Therapeutic Drugs Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Radioactive Therapeutic Drugs Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Radioactive Therapeutic Drugs in 2022
3.2.3 Global Concentration Ratios (CR8) for Radioactive Therapeutic Drugs in 2022
3.3 Radioactive Therapeutic Drugs Company Evaluation Quadrant
3.4 Radioactive Therapeutic Drugs Market: Overall Company Footprint Analysis
3.4.1 Radioactive Therapeutic Drugs Market: Region Footprint
3.4.2 Radioactive Therapeutic Drugs Market: Company Product Type Footprint
3.4.3 Radioactive Therapeutic Drugs Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Radioactive Therapeutic Drugs Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Radioactive Therapeutic Drugs Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Radioactive Therapeutic Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Radioactive Therapeutic Drugs Consumption Value Comparison
4.2.1 United States VS China: Radioactive Therapeutic Drugs Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Radioactive Therapeutic Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Radioactive Therapeutic Drugs Companies and Market Share, 2018-2023
4.3.1 United States Based Radioactive Therapeutic Drugs Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Radioactive Therapeutic Drugs Revenue, (2018-2023)
4.4 China Based Companies Radioactive Therapeutic Drugs Revenue and Market Share, 2018-2023
4.4.1 China Based Radioactive Therapeutic Drugs Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Radioactive Therapeutic Drugs Revenue, (2018-2023)
4.5 Rest of World Based Radioactive Therapeutic Drugs Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Radioactive Therapeutic Drugs Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Radioactive Therapeutic Drugs Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Radioactive Therapeutic Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Oncology
5.2.2 Cardiology
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Radioactive Therapeutic Drugs Market Size by Type (2018-2023)
5.3.2 World Radioactive Therapeutic Drugs Market Size by Type (2024-2029)
5.3.3 World Radioactive Therapeutic Drugs Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Radioactive Therapeutic Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospitals
6.2.2 Academic & Research Institutes
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Radioactive Therapeutic Drugs Market Size by Application (2018-2023)
6.3.2 World Radioactive Therapeutic Drugs Market Size by Application (2024-2029)
6.3.3 World Radioactive Therapeutic Drugs Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Nihon Medi-Physics
7.1.1 Nihon Medi-Physics Details
7.1.2 Nihon Medi-Physics Major Business
7.1.3 Nihon Medi-Physics Radioactive Therapeutic Drugs Product and Services
7.1.4 Nihon Medi-Physics Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Nihon Medi-Physics Recent Developments/Updates
7.1.6 Nihon Medi-Physics Competitive Strengths & Weaknesses
7.2 ITM Isotopen Technologien Mьnchen AG
7.2.1 ITM Isotopen Technologien Mьnchen AG Details
7.2.2 ITM Isotopen Technologien Mьnchen AG Major Business
7.2.3 ITM Isotopen Technologien Mьnchen AG Radioactive Therapeutic Drugs Product and Services
7.2.4 ITM Isotopen Technologien Mьnchen AG Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 ITM Isotopen Technologien Mьnchen AG Recent Developments/Updates
7.2.6 ITM Isotopen Technologien Mьnchen AG Competitive Strengths & Weaknesses
7.3 Advanced Accelerator Applications
7.3.1 Advanced Accelerator Applications Details
7.3.2 Advanced Accelerator Applications Major Business
7.3.3 Advanced Accelerator Applications Radioactive Therapeutic Drugs Product and Services
7.3.4 Advanced Accelerator Applications Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Advanced Accelerator Applications Recent Developments/Updates
7.3.6 Advanced Accelerator Applications Competitive Strengths & Weaknesses
7.4 Telix Pharmaceuticals
7.4.1 Telix Pharmaceuticals Details
7.4.2 Telix Pharmaceuticals Major Business
7.4.3 Telix Pharmaceuticals Radioactive Therapeutic Drugs Product and Services
7.4.4 Telix Pharmaceuticals Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Telix Pharmaceuticals Recent Developments/Updates
7.4.6 Telix Pharmaceuticals Competitive Strengths & Weaknesses
7.5 GE Healthcare
7.5.1 GE Healthcare Details
7.5.2 GE Healthcare Major Business
7.5.3 GE Healthcare Radioactive Therapeutic Drugs Product and Services
7.5.4 GE Healthcare Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 GE Healthcare Recent Developments/Updates
7.5.6 GE Healthcare Competitive Strengths & Weaknesses
7.6 Theragnostics Ltd.
7.6.1 Theragnostics Ltd. Details
7.6.2 Theragnostics Ltd. Major Business
7.6.3 Theragnostics Ltd. Radioactive Therapeutic Drugs Product and Services
7.6.4 Theragnostics Ltd. Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Theragnostics Ltd. Recent Developments/Updates
7.6.6 Theragnostics Ltd. Competitive Strengths & Weaknesses
7.7 NuView Life Sciences
7.7.1 NuView Life Sciences Details
7.7.2 NuView Life Sciences Major Business
7.7.3 NuView Life Sciences Radioactive Therapeutic Drugs Product and Services
7.7.4 NuView Life Sciences Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 NuView Life Sciences Recent Developments/Updates
7.7.6 NuView Life Sciences Competitive Strengths & Weaknesses
7.8 Jubilant Pharma Limited
7.8.1 Jubilant Pharma Limited Details
7.8.2 Jubilant Pharma Limited Major Business
7.8.3 Jubilant Pharma Limited Radioactive Therapeutic Drugs Product and Services
7.8.4 Jubilant Pharma Limited Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Jubilant Pharma Limited Recent Developments/Updates
7.8.6 Jubilant Pharma Limited Competitive Strengths & Weaknesses
7.9 Lantheus Holdings, Inc.
7.9.1 Lantheus Holdings, Inc. Details
7.9.2 Lantheus Holdings, Inc. Major Business
7.9.3 Lantheus Holdings, Inc. Radioactive Therapeutic Drugs Product and Services
7.9.4 Lantheus Holdings, Inc. Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Lantheus Holdings, Inc. Recent Developments/Updates
7.9.6 Lantheus Holdings, Inc. Competitive Strengths & Weaknesses
7.10 Curium Pharma
7.10.1 Curium Pharma Details
7.10.2 Curium Pharma Major Business
7.10.3 Curium Pharma Radioactive Therapeutic Drugs Product and Services
7.10.4 Curium Pharma Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Curium Pharma Recent Developments/Updates
7.10.6 Curium Pharma Competitive Strengths & Weaknesses
7.11 Bayer AG
7.11.1 Bayer AG Details
7.11.2 Bayer AG Major Business
7.11.3 Bayer AG Radioactive Therapeutic Drugs Product and Services
7.11.4 Bayer AG Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Bayer AG Recent Developments/Updates
7.11.6 Bayer AG Competitive Strengths & Weaknesses
7.12 Clarity Pharmaceuticals
7.12.1 Clarity Pharmaceuticals Details
7.12.2 Clarity Pharmaceuticals Major Business
7.12.3 Clarity Pharmaceuticals Radioactive Therapeutic Drugs Product and Services
7.12.4 Clarity Pharmaceuticals Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Clarity Pharmaceuticals Recent Developments/Updates
7.12.6 Clarity Pharmaceuticals Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Radioactive Therapeutic Drugs Industry Chain
8.2 Radioactive Therapeutic Drugs Upstream Analysis
8.3 Radioactive Therapeutic Drugs Midstream Analysis
8.4 Radioactive Therapeutic Drugs Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Radioactive Therapeutic Drugs Introduction
1.2 World Radioactive Therapeutic Drugs Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Radioactive Therapeutic Drugs Total Market by Region (by Headquarter Location)
1.3.1 World Radioactive Therapeutic Drugs Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Radioactive Therapeutic Drugs Market Size (2018-2029)
1.3.3 China Radioactive Therapeutic Drugs Market Size (2018-2029)
1.3.4 Europe Radioactive Therapeutic Drugs Market Size (2018-2029)
1.3.5 Japan Radioactive Therapeutic Drugs Market Size (2018-2029)
1.3.6 South Korea Radioactive Therapeutic Drugs Market Size (2018-2029)
1.3.7 ASEAN Radioactive Therapeutic Drugs Market Size (2018-2029)
1.3.8 India Radioactive Therapeutic Drugs Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Radioactive Therapeutic Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Radioactive Therapeutic Drugs Major Market Trends
2 DEMAND SUMMARY
2.1 World Radioactive Therapeutic Drugs Consumption Value (2018-2029)
2.2 World Radioactive Therapeutic Drugs Consumption Value by Region
2.2.1 World Radioactive Therapeutic Drugs Consumption Value by Region (2018-2023)
2.2.2 World Radioactive Therapeutic Drugs Consumption Value Forecast by Region (2024-2029)
2.3 United States Radioactive Therapeutic Drugs Consumption Value (2018-2029)
2.4 China Radioactive Therapeutic Drugs Consumption Value (2018-2029)
2.5 Europe Radioactive Therapeutic Drugs Consumption Value (2018-2029)
2.6 Japan Radioactive Therapeutic Drugs Consumption Value (2018-2029)
2.7 South Korea Radioactive Therapeutic Drugs Consumption Value (2018-2029)
2.8 ASEAN Radioactive Therapeutic Drugs Consumption Value (2018-2029)
2.9 India Radioactive Therapeutic Drugs Consumption Value (2018-2029)
3 WORLD RADIOACTIVE THERAPEUTIC DRUGS COMPANIES COMPETITIVE ANALYSIS
3.1 World Radioactive Therapeutic Drugs Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Radioactive Therapeutic Drugs Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Radioactive Therapeutic Drugs in 2022
3.2.3 Global Concentration Ratios (CR8) for Radioactive Therapeutic Drugs in 2022
3.3 Radioactive Therapeutic Drugs Company Evaluation Quadrant
3.4 Radioactive Therapeutic Drugs Market: Overall Company Footprint Analysis
3.4.1 Radioactive Therapeutic Drugs Market: Region Footprint
3.4.2 Radioactive Therapeutic Drugs Market: Company Product Type Footprint
3.4.3 Radioactive Therapeutic Drugs Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Radioactive Therapeutic Drugs Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Radioactive Therapeutic Drugs Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Radioactive Therapeutic Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Radioactive Therapeutic Drugs Consumption Value Comparison
4.2.1 United States VS China: Radioactive Therapeutic Drugs Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Radioactive Therapeutic Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Radioactive Therapeutic Drugs Companies and Market Share, 2018-2023
4.3.1 United States Based Radioactive Therapeutic Drugs Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Radioactive Therapeutic Drugs Revenue, (2018-2023)
4.4 China Based Companies Radioactive Therapeutic Drugs Revenue and Market Share, 2018-2023
4.4.1 China Based Radioactive Therapeutic Drugs Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Radioactive Therapeutic Drugs Revenue, (2018-2023)
4.5 Rest of World Based Radioactive Therapeutic Drugs Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Radioactive Therapeutic Drugs Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Radioactive Therapeutic Drugs Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Radioactive Therapeutic Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Oncology
5.2.2 Cardiology
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Radioactive Therapeutic Drugs Market Size by Type (2018-2023)
5.3.2 World Radioactive Therapeutic Drugs Market Size by Type (2024-2029)
5.3.3 World Radioactive Therapeutic Drugs Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Radioactive Therapeutic Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospitals
6.2.2 Academic & Research Institutes
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Radioactive Therapeutic Drugs Market Size by Application (2018-2023)
6.3.2 World Radioactive Therapeutic Drugs Market Size by Application (2024-2029)
6.3.3 World Radioactive Therapeutic Drugs Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Nihon Medi-Physics
7.1.1 Nihon Medi-Physics Details
7.1.2 Nihon Medi-Physics Major Business
7.1.3 Nihon Medi-Physics Radioactive Therapeutic Drugs Product and Services
7.1.4 Nihon Medi-Physics Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Nihon Medi-Physics Recent Developments/Updates
7.1.6 Nihon Medi-Physics Competitive Strengths & Weaknesses
7.2 ITM Isotopen Technologien Mьnchen AG
7.2.1 ITM Isotopen Technologien Mьnchen AG Details
7.2.2 ITM Isotopen Technologien Mьnchen AG Major Business
7.2.3 ITM Isotopen Technologien Mьnchen AG Radioactive Therapeutic Drugs Product and Services
7.2.4 ITM Isotopen Technologien Mьnchen AG Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 ITM Isotopen Technologien Mьnchen AG Recent Developments/Updates
7.2.6 ITM Isotopen Technologien Mьnchen AG Competitive Strengths & Weaknesses
7.3 Advanced Accelerator Applications
7.3.1 Advanced Accelerator Applications Details
7.3.2 Advanced Accelerator Applications Major Business
7.3.3 Advanced Accelerator Applications Radioactive Therapeutic Drugs Product and Services
7.3.4 Advanced Accelerator Applications Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Advanced Accelerator Applications Recent Developments/Updates
7.3.6 Advanced Accelerator Applications Competitive Strengths & Weaknesses
7.4 Telix Pharmaceuticals
7.4.1 Telix Pharmaceuticals Details
7.4.2 Telix Pharmaceuticals Major Business
7.4.3 Telix Pharmaceuticals Radioactive Therapeutic Drugs Product and Services
7.4.4 Telix Pharmaceuticals Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Telix Pharmaceuticals Recent Developments/Updates
7.4.6 Telix Pharmaceuticals Competitive Strengths & Weaknesses
7.5 GE Healthcare
7.5.1 GE Healthcare Details
7.5.2 GE Healthcare Major Business
7.5.3 GE Healthcare Radioactive Therapeutic Drugs Product and Services
7.5.4 GE Healthcare Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 GE Healthcare Recent Developments/Updates
7.5.6 GE Healthcare Competitive Strengths & Weaknesses
7.6 Theragnostics Ltd.
7.6.1 Theragnostics Ltd. Details
7.6.2 Theragnostics Ltd. Major Business
7.6.3 Theragnostics Ltd. Radioactive Therapeutic Drugs Product and Services
7.6.4 Theragnostics Ltd. Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Theragnostics Ltd. Recent Developments/Updates
7.6.6 Theragnostics Ltd. Competitive Strengths & Weaknesses
7.7 NuView Life Sciences
7.7.1 NuView Life Sciences Details
7.7.2 NuView Life Sciences Major Business
7.7.3 NuView Life Sciences Radioactive Therapeutic Drugs Product and Services
7.7.4 NuView Life Sciences Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 NuView Life Sciences Recent Developments/Updates
7.7.6 NuView Life Sciences Competitive Strengths & Weaknesses
7.8 Jubilant Pharma Limited
7.8.1 Jubilant Pharma Limited Details
7.8.2 Jubilant Pharma Limited Major Business
7.8.3 Jubilant Pharma Limited Radioactive Therapeutic Drugs Product and Services
7.8.4 Jubilant Pharma Limited Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Jubilant Pharma Limited Recent Developments/Updates
7.8.6 Jubilant Pharma Limited Competitive Strengths & Weaknesses
7.9 Lantheus Holdings, Inc.
7.9.1 Lantheus Holdings, Inc. Details
7.9.2 Lantheus Holdings, Inc. Major Business
7.9.3 Lantheus Holdings, Inc. Radioactive Therapeutic Drugs Product and Services
7.9.4 Lantheus Holdings, Inc. Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Lantheus Holdings, Inc. Recent Developments/Updates
7.9.6 Lantheus Holdings, Inc. Competitive Strengths & Weaknesses
7.10 Curium Pharma
7.10.1 Curium Pharma Details
7.10.2 Curium Pharma Major Business
7.10.3 Curium Pharma Radioactive Therapeutic Drugs Product and Services
7.10.4 Curium Pharma Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Curium Pharma Recent Developments/Updates
7.10.6 Curium Pharma Competitive Strengths & Weaknesses
7.11 Bayer AG
7.11.1 Bayer AG Details
7.11.2 Bayer AG Major Business
7.11.3 Bayer AG Radioactive Therapeutic Drugs Product and Services
7.11.4 Bayer AG Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Bayer AG Recent Developments/Updates
7.11.6 Bayer AG Competitive Strengths & Weaknesses
7.12 Clarity Pharmaceuticals
7.12.1 Clarity Pharmaceuticals Details
7.12.2 Clarity Pharmaceuticals Major Business
7.12.3 Clarity Pharmaceuticals Radioactive Therapeutic Drugs Product and Services
7.12.4 Clarity Pharmaceuticals Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Clarity Pharmaceuticals Recent Developments/Updates
7.12.6 Clarity Pharmaceuticals Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Radioactive Therapeutic Drugs Industry Chain
8.2 Radioactive Therapeutic Drugs Upstream Analysis
8.3 Radioactive Therapeutic Drugs Midstream Analysis
8.4 Radioactive Therapeutic Drugs Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Radioactive Therapeutic Drugs Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Radioactive Therapeutic Drugs Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Radioactive Therapeutic Drugs Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Radioactive Therapeutic Drugs Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Radioactive Therapeutic Drugs Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Radioactive Therapeutic Drugs Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Radioactive Therapeutic Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Radioactive Therapeutic Drugs Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Radioactive Therapeutic Drugs Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Radioactive Therapeutic Drugs Players in 2022
Table 12. World Radioactive Therapeutic Drugs Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Radioactive Therapeutic Drugs Company Evaluation Quadrant
Table 14. Head Office of Key Radioactive Therapeutic Drugs Player
Table 15. Radioactive Therapeutic Drugs Market: Company Product Type Footprint
Table 16. Radioactive Therapeutic Drugs Market: Company Product Application Footprint
Table 17. Radioactive Therapeutic Drugs Mergers & Acquisitions Activity
Table 18. United States VS China Radioactive Therapeutic Drugs Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Radioactive Therapeutic Drugs Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Radioactive Therapeutic Drugs Companies, Headquarters (States, Country)
Table 21. United States Based Companies Radioactive Therapeutic Drugs Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Radioactive Therapeutic Drugs Revenue Market Share (2018-2023)
Table 23. China Based Radioactive Therapeutic Drugs Companies, Headquarters (Province, Country)
Table 24. China Based Companies Radioactive Therapeutic Drugs Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Radioactive Therapeutic Drugs Revenue Market Share (2018-2023)
Table 26. Rest of World Based Radioactive Therapeutic Drugs Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Radioactive Therapeutic Drugs Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Radioactive Therapeutic Drugs Revenue Market Share (2018-2023)
Table 29. World Radioactive Therapeutic Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Radioactive Therapeutic Drugs Market Size by Type (2018-2023) & (USD Million)
Table 31. World Radioactive Therapeutic Drugs Market Size by Type (2024-2029) & (USD Million)
Table 32. World Radioactive Therapeutic Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Radioactive Therapeutic Drugs Market Size by Application (2018-2023) & (USD Million)
Table 34. World Radioactive Therapeutic Drugs Market Size by Application (2024-2029) & (USD Million)
Table 35. Nihon Medi-Physics Basic Information, Area Served and Competitors
Table 36. Nihon Medi-Physics Major Business
Table 37. Nihon Medi-Physics Radioactive Therapeutic Drugs Product and Services
Table 38. Nihon Medi-Physics Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Nihon Medi-Physics Recent Developments/Updates
Table 40. Nihon Medi-Physics Competitive Strengths & Weaknesses
Table 41. ITM Isotopen Technologien Mьnchen AG Basic Information, Area Served and Competitors
Table 42. ITM Isotopen Technologien Mьnchen AG Major Business
Table 43. ITM Isotopen Technologien Mьnchen AG Radioactive Therapeutic Drugs Product and Services
Table 44. ITM Isotopen Technologien Mьnchen AG Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. ITM Isotopen Technologien Mьnchen AG Recent Developments/Updates
Table 46. ITM Isotopen Technologien Mьnchen AG Competitive Strengths & Weaknesses
Table 47. Advanced Accelerator Applications Basic Information, Area Served and Competitors
Table 48. Advanced Accelerator Applications Major Business
Table 49. Advanced Accelerator Applications Radioactive Therapeutic Drugs Product and Services
Table 50. Advanced Accelerator Applications Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Advanced Accelerator Applications Recent Developments/Updates
Table 52. Advanced Accelerator Applications Competitive Strengths & Weaknesses
Table 53. Telix Pharmaceuticals Basic Information, Area Served and Competitors
Table 54. Telix Pharmaceuticals Major Business
Table 55. Telix Pharmaceuticals Radioactive Therapeutic Drugs Product and Services
Table 56. Telix Pharmaceuticals Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Telix Pharmaceuticals Recent Developments/Updates
Table 58. Telix Pharmaceuticals Competitive Strengths & Weaknesses
Table 59. GE Healthcare Basic Information, Area Served and Competitors
Table 60. GE Healthcare Major Business
Table 61. GE Healthcare Radioactive Therapeutic Drugs Product and Services
Table 62. GE Healthcare Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. GE Healthcare Recent Developments/Updates
Table 64. GE Healthcare Competitive Strengths & Weaknesses
Table 65. Theragnostics Ltd. Basic Information, Area Served and Competitors
Table 66. Theragnostics Ltd. Major Business
Table 67. Theragnostics Ltd. Radioactive Therapeutic Drugs Product and Services
Table 68. Theragnostics Ltd. Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Theragnostics Ltd. Recent Developments/Updates
Table 70. Theragnostics Ltd. Competitive Strengths & Weaknesses
Table 71. NuView Life Sciences Basic Information, Area Served and Competitors
Table 72. NuView Life Sciences Major Business
Table 73. NuView Life Sciences Radioactive Therapeutic Drugs Product and Services
Table 74. NuView Life Sciences Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. NuView Life Sciences Recent Developments/Updates
Table 76. NuView Life Sciences Competitive Strengths & Weaknesses
Table 77. Jubilant Pharma Limited Basic Information, Area Served and Competitors
Table 78. Jubilant Pharma Limited Major Business
Table 79. Jubilant Pharma Limited Radioactive Therapeutic Drugs Product and Services
Table 80. Jubilant Pharma Limited Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Jubilant Pharma Limited Recent Developments/Updates
Table 82. Jubilant Pharma Limited Competitive Strengths & Weaknesses
Table 83. Lantheus Holdings, Inc. Basic Information, Area Served and Competitors
Table 84. Lantheus Holdings, Inc. Major Business
Table 85. Lantheus Holdings, Inc. Radioactive Therapeutic Drugs Product and Services
Table 86. Lantheus Holdings, Inc. Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Lantheus Holdings, Inc. Recent Developments/Updates
Table 88. Lantheus Holdings, Inc. Competitive Strengths & Weaknesses
Table 89. Curium Pharma Basic Information, Area Served and Competitors
Table 90. Curium Pharma Major Business
Table 91. Curium Pharma Radioactive Therapeutic Drugs Product and Services
Table 92. Curium Pharma Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Curium Pharma Recent Developments/Updates
Table 94. Curium Pharma Competitive Strengths & Weaknesses
Table 95. Bayer AG Basic Information, Area Served and Competitors
Table 96. Bayer AG Major Business
Table 97. Bayer AG Radioactive Therapeutic Drugs Product and Services
Table 98. Bayer AG Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Bayer AG Recent Developments/Updates
Table 100. Clarity Pharmaceuticals Basic Information, Area Served and Competitors
Table 101. Clarity Pharmaceuticals Major Business
Table 102. Clarity Pharmaceuticals Radioactive Therapeutic Drugs Product and Services
Table 103. Clarity Pharmaceuticals Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 104. Global Key Players of Radioactive Therapeutic Drugs Upstream (Raw Materials)
Table 105. Radioactive Therapeutic Drugs Typical Customers
LIST OF FIGURE
Figure 1. Radioactive Therapeutic Drugs Picture
Figure 2. World Radioactive Therapeutic Drugs Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Radioactive Therapeutic Drugs Total Market Size (2018-2029) & (USD Million)
Figure 4. World Radioactive Therapeutic Drugs Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Radioactive Therapeutic Drugs Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Radioactive Therapeutic Drugs Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Radioactive Therapeutic Drugs Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Radioactive Therapeutic Drugs Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Radioactive Therapeutic Drugs Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Radioactive Therapeutic Drugs Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Radioactive Therapeutic Drugs Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Radioactive Therapeutic Drugs Revenue (2018-2029) & (USD Million)
Figure 13. Radioactive Therapeutic Drugs Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 16. World Radioactive Therapeutic Drugs Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 18. China Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. India Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Radioactive Therapeutic Drugs by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Radioactive Therapeutic Drugs Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Radioactive Therapeutic Drugs Markets in 2022
Figure 27. United States VS China: Radioactive Therapeutic Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Radioactive Therapeutic Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Radioactive Therapeutic Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Radioactive Therapeutic Drugs Market Size Market Share by Type in 2022
Figure 31. Oncology
Figure 32. Cardiology
Figure 33. Others
Figure 34. World Radioactive Therapeutic Drugs Market Size Market Share by Type (2018-2029)
Figure 35. World Radioactive Therapeutic Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Radioactive Therapeutic Drugs Market Size Market Share by Application in 2022
Figure 37. Hospitals
Figure 38. Academic & Research Institutes
Figure 39. Others
Figure 40. Radioactive Therapeutic Drugs Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Table 1. World Radioactive Therapeutic Drugs Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Radioactive Therapeutic Drugs Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Radioactive Therapeutic Drugs Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Radioactive Therapeutic Drugs Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Radioactive Therapeutic Drugs Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Radioactive Therapeutic Drugs Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Radioactive Therapeutic Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Radioactive Therapeutic Drugs Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Radioactive Therapeutic Drugs Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Radioactive Therapeutic Drugs Players in 2022
Table 12. World Radioactive Therapeutic Drugs Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Radioactive Therapeutic Drugs Company Evaluation Quadrant
Table 14. Head Office of Key Radioactive Therapeutic Drugs Player
Table 15. Radioactive Therapeutic Drugs Market: Company Product Type Footprint
Table 16. Radioactive Therapeutic Drugs Market: Company Product Application Footprint
Table 17. Radioactive Therapeutic Drugs Mergers & Acquisitions Activity
Table 18. United States VS China Radioactive Therapeutic Drugs Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Radioactive Therapeutic Drugs Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Radioactive Therapeutic Drugs Companies, Headquarters (States, Country)
Table 21. United States Based Companies Radioactive Therapeutic Drugs Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Radioactive Therapeutic Drugs Revenue Market Share (2018-2023)
Table 23. China Based Radioactive Therapeutic Drugs Companies, Headquarters (Province, Country)
Table 24. China Based Companies Radioactive Therapeutic Drugs Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Radioactive Therapeutic Drugs Revenue Market Share (2018-2023)
Table 26. Rest of World Based Radioactive Therapeutic Drugs Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Radioactive Therapeutic Drugs Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Radioactive Therapeutic Drugs Revenue Market Share (2018-2023)
Table 29. World Radioactive Therapeutic Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Radioactive Therapeutic Drugs Market Size by Type (2018-2023) & (USD Million)
Table 31. World Radioactive Therapeutic Drugs Market Size by Type (2024-2029) & (USD Million)
Table 32. World Radioactive Therapeutic Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Radioactive Therapeutic Drugs Market Size by Application (2018-2023) & (USD Million)
Table 34. World Radioactive Therapeutic Drugs Market Size by Application (2024-2029) & (USD Million)
Table 35. Nihon Medi-Physics Basic Information, Area Served and Competitors
Table 36. Nihon Medi-Physics Major Business
Table 37. Nihon Medi-Physics Radioactive Therapeutic Drugs Product and Services
Table 38. Nihon Medi-Physics Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Nihon Medi-Physics Recent Developments/Updates
Table 40. Nihon Medi-Physics Competitive Strengths & Weaknesses
Table 41. ITM Isotopen Technologien Mьnchen AG Basic Information, Area Served and Competitors
Table 42. ITM Isotopen Technologien Mьnchen AG Major Business
Table 43. ITM Isotopen Technologien Mьnchen AG Radioactive Therapeutic Drugs Product and Services
Table 44. ITM Isotopen Technologien Mьnchen AG Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. ITM Isotopen Technologien Mьnchen AG Recent Developments/Updates
Table 46. ITM Isotopen Technologien Mьnchen AG Competitive Strengths & Weaknesses
Table 47. Advanced Accelerator Applications Basic Information, Area Served and Competitors
Table 48. Advanced Accelerator Applications Major Business
Table 49. Advanced Accelerator Applications Radioactive Therapeutic Drugs Product and Services
Table 50. Advanced Accelerator Applications Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Advanced Accelerator Applications Recent Developments/Updates
Table 52. Advanced Accelerator Applications Competitive Strengths & Weaknesses
Table 53. Telix Pharmaceuticals Basic Information, Area Served and Competitors
Table 54. Telix Pharmaceuticals Major Business
Table 55. Telix Pharmaceuticals Radioactive Therapeutic Drugs Product and Services
Table 56. Telix Pharmaceuticals Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Telix Pharmaceuticals Recent Developments/Updates
Table 58. Telix Pharmaceuticals Competitive Strengths & Weaknesses
Table 59. GE Healthcare Basic Information, Area Served and Competitors
Table 60. GE Healthcare Major Business
Table 61. GE Healthcare Radioactive Therapeutic Drugs Product and Services
Table 62. GE Healthcare Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. GE Healthcare Recent Developments/Updates
Table 64. GE Healthcare Competitive Strengths & Weaknesses
Table 65. Theragnostics Ltd. Basic Information, Area Served and Competitors
Table 66. Theragnostics Ltd. Major Business
Table 67. Theragnostics Ltd. Radioactive Therapeutic Drugs Product and Services
Table 68. Theragnostics Ltd. Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Theragnostics Ltd. Recent Developments/Updates
Table 70. Theragnostics Ltd. Competitive Strengths & Weaknesses
Table 71. NuView Life Sciences Basic Information, Area Served and Competitors
Table 72. NuView Life Sciences Major Business
Table 73. NuView Life Sciences Radioactive Therapeutic Drugs Product and Services
Table 74. NuView Life Sciences Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. NuView Life Sciences Recent Developments/Updates
Table 76. NuView Life Sciences Competitive Strengths & Weaknesses
Table 77. Jubilant Pharma Limited Basic Information, Area Served and Competitors
Table 78. Jubilant Pharma Limited Major Business
Table 79. Jubilant Pharma Limited Radioactive Therapeutic Drugs Product and Services
Table 80. Jubilant Pharma Limited Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Jubilant Pharma Limited Recent Developments/Updates
Table 82. Jubilant Pharma Limited Competitive Strengths & Weaknesses
Table 83. Lantheus Holdings, Inc. Basic Information, Area Served and Competitors
Table 84. Lantheus Holdings, Inc. Major Business
Table 85. Lantheus Holdings, Inc. Radioactive Therapeutic Drugs Product and Services
Table 86. Lantheus Holdings, Inc. Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Lantheus Holdings, Inc. Recent Developments/Updates
Table 88. Lantheus Holdings, Inc. Competitive Strengths & Weaknesses
Table 89. Curium Pharma Basic Information, Area Served and Competitors
Table 90. Curium Pharma Major Business
Table 91. Curium Pharma Radioactive Therapeutic Drugs Product and Services
Table 92. Curium Pharma Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Curium Pharma Recent Developments/Updates
Table 94. Curium Pharma Competitive Strengths & Weaknesses
Table 95. Bayer AG Basic Information, Area Served and Competitors
Table 96. Bayer AG Major Business
Table 97. Bayer AG Radioactive Therapeutic Drugs Product and Services
Table 98. Bayer AG Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Bayer AG Recent Developments/Updates
Table 100. Clarity Pharmaceuticals Basic Information, Area Served and Competitors
Table 101. Clarity Pharmaceuticals Major Business
Table 102. Clarity Pharmaceuticals Radioactive Therapeutic Drugs Product and Services
Table 103. Clarity Pharmaceuticals Radioactive Therapeutic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 104. Global Key Players of Radioactive Therapeutic Drugs Upstream (Raw Materials)
Table 105. Radioactive Therapeutic Drugs Typical Customers
LIST OF FIGURE
Figure 1. Radioactive Therapeutic Drugs Picture
Figure 2. World Radioactive Therapeutic Drugs Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Radioactive Therapeutic Drugs Total Market Size (2018-2029) & (USD Million)
Figure 4. World Radioactive Therapeutic Drugs Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Radioactive Therapeutic Drugs Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Radioactive Therapeutic Drugs Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Radioactive Therapeutic Drugs Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Radioactive Therapeutic Drugs Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Radioactive Therapeutic Drugs Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Radioactive Therapeutic Drugs Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Radioactive Therapeutic Drugs Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Radioactive Therapeutic Drugs Revenue (2018-2029) & (USD Million)
Figure 13. Radioactive Therapeutic Drugs Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 16. World Radioactive Therapeutic Drugs Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 18. China Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. India Radioactive Therapeutic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Radioactive Therapeutic Drugs by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Radioactive Therapeutic Drugs Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Radioactive Therapeutic Drugs Markets in 2022
Figure 27. United States VS China: Radioactive Therapeutic Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Radioactive Therapeutic Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Radioactive Therapeutic Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Radioactive Therapeutic Drugs Market Size Market Share by Type in 2022
Figure 31. Oncology
Figure 32. Cardiology
Figure 33. Others
Figure 34. World Radioactive Therapeutic Drugs Market Size Market Share by Type (2018-2029)
Figure 35. World Radioactive Therapeutic Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Radioactive Therapeutic Drugs Market Size Market Share by Application in 2022
Figure 37. Hospitals
Figure 38. Academic & Research Institutes
Figure 39. Others
Figure 40. Radioactive Therapeutic Drugs Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
